Development of SFV-based plasmid electroporation for use in tumour treatment and vaccine delivery
Citation:
John M. Piggott, 'Development of SFV-based plasmid electroporation for use in tumour treatment and vaccine delivery', [thesis], Trinity College (Dublin, Ireland). Department of Microbiology, 2008, pp 247Download Item:
Piggott TCD THESIS 8358 Development of.pdf (PDF) 113.0Mb
Abstract:
Electroporation is the delivery of short and intense electric pulses into living cells
(either in tissue or suspension), which results in a transient and reversible increase in
permeability of the cell transmembrane. This study is designed to develop
electroporation for use as a method of Semliki Forest virus (SFV) - based plasmid
delivery for both tumour treatment and vaccine delivery.
Author: Piggott, John M.
Advisor:
Atkins, GregoryQualification name:
Doctor of Philosophy (Ph.D.)Publisher:
Trinity College (Dublin, Ireland). Department of MicrobiologyNote:
TARA (Trinity's Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ieType of material:
thesisAvailability:
Full text availableKeywords:
Microbiology, Ph.D., Ph.D. Trinity College DublinLicences: